Explore 3 Stock Ideas & Industry Insights Download Free Report

908 Devices Inc

Company price
10.56 USD 0.41 ( 4.04%)
Last update at 2026-11-06T21:26:00Z
VOLUME
332773
Market Cap
412.10M

Momentum Score

…

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
10.10
Low
10.76
High
52 Week Price Range
5.03
Low
11.25
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
10.15
Dividend Yield
-
Revenue TTM
60.84M
Revenue Per Share
1.66
Gross Profit TTM
32.03M
Debt / Equity
0.12
ROE
-24.95%
Net Debt
-96.26M
ROCE
-21.37%
Diluted EPS TTM
-0.95

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -33.34M -72.49M -36.61M -33.56M -22.17M
Net income -36.64M -72.21M -36.40M -31.74M -22.12M
Selling general administrative 38.53M 53.64M 46.23M 43.88M 32.23M
Gross profit 26.80M 29.93M 25.32M 26.02M 23.23M
Reconciled depreciation 4.46M 4.68M 2.56M 1.61M 0.93M
Ebit -33.34M -48.56M -42.65M -37.00M -22.07M
Ebitda -28.88M -43.88M -40.27M -35.38M -21.68M
Depreciation and amortization 4.46M 4.68M 2.38M 1.61M 0.39M
Non operating income net other - - - 1.95M 0.39M
Operating income -24.18M -76.72M -42.76M -35.38M -22.07M
Other operating expenses 80.38M 136.35M 92.99M 82.23M 64.28M
Interest expense - 0.00M 0.20M 0.13M 0.49M
Tax provision -0.07M -0.28M -0.21M - -
Interest income 4.14M 4.49M 4.74M 2.03M -
Net interest income 4.14M 4.49M 4.48M 1.90M -0.49M
Income tax expense -0.07M -0.28M -0.21M -1.82M -0.05M
Total revenue 56.20M 59.63M 50.23M 46.85M 42.21M
Total operating expenses 50.98M 106.64M 68.08M 61.41M 45.30M
Cost of revenue 29.40M 29.71M 24.91M 20.83M 18.97M
Total other income expense net -9.16M 4.23M 6.15M 1.82M -0.10M
Net income from continuing ops -33.28M -72.21M -38.76M -33.56M -22.17M
Net income applicable to common shares - - - -33.56M -22.17M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 190.07M 159.48M 202.98M 242.59M 260.91M
Intangible assets 36.41M 45.26M 7.86M 8.49M -
Other current assets 7.27M 4.66M 4.18M 4.66M 4.53M
Total liab 46.37M 44.88M 37.49M 51.99M 46.30M
Total stockholder equity 143.70M 114.59M 165.49M 190.60M 214.60M
Deferred long term liab - - - 2.67M -
Other current liab 16.02M 9.10M 8.71M 8.85M 6.96M
Common stock 0.04M 0.04M 0.03M 0.03M 0.03M
Capital stock 0.04M 0.04M 0.03M 0.03M 0.03M
Retained earnings -223.32M -242.81M -170.60M -134.20M -100.64M
Other liab - - - 14.72M 11.96M
Good will - 0.00M 10.37M 10.05M -
Other assets - - - 1.38M 1.23M
Cash 112.97M 44.03M 121.04M 188.42M 224.07M
Total current liabilities 34.06M 25.15M 22.55M 19.23M 14.84M
Current deferred revenue 8.93M 12.12M 10.63M 7.51M 5.16M
Net debt -96.26M -37.42M -115.10M -171.95M -203.22M
Short term debt 16.71M 1.86M 2.02M 1.47M 1.34M
Short long term debt total 16.71M 6.61M 5.95M 16.47M 20.85M
Other stockholder equity 366.93M 356.22M 334.69M 323.97M 315.21M
Property plant equipment - - - 3.08M 6.79M
Total current assets 144.56M 103.06M 173.79M 215.63M 252.89M
Net tangible assets - - - 172.06M 214.60M
Short term investments 42.45M 25.57M 24.64M - -
Net receivables 11.33M 12.63M 8.99M 10.03M 16.38M
Long term debt - - - 15.00M 15.00M
Inventory 12.99M 16.17M 14.94M 12.51M 7.92M
Accounts payable 8.42M 2.06M 1.19M 1.40M 1.37M
Accumulated other comprehensive income 0.05M 1.15M 1.36M 0.80M -
Common stock total equity - - - 0.03M 0.03M
Retained earnings total equity - - - -134.20M -100.64M
Non currrent assets other 0.47M 0.83M -1.22M -1.29M 1.23M
Non current assets total 45.51M 56.42M 29.19M 26.96M 8.01M
Capital lease obligations 4.63M 6.61M 5.95M 1.47M 5.85M
Long term debt total - - - 15.00M 15.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -16.21M -46.32M -31.65M -15.81M -0.74M
Change to liabilities - - - 0.38M 2.56M
Total cashflows from investing activities 50.75M -46.32M -26.40M -15.81M -0.74M
Net borrowings - 0.00M -15.00M - -0.04M
Total cash from financing activities -0.70M -0.38M -15.94M 1.18M 94.72M
Change to operating activities - - - 0.56M -4.86M
Net income 19.49M -72.21M -36.40M -33.56M -22.17M
Change in cash 26.39M -77.01M -67.38M -35.54M 64.91M
Begin period cash flow 44.20M 121.21M 188.59M 224.13M 159.23M
End period cash flow 70.59M 44.20M 121.21M 188.59M 224.13M
Total cash from operating activities -23.69M -30.25M -25.06M -20.93M -29.08M
Issuance of capital stock 0.86M 1.15M 1.14M 1.55M 94.75M
Depreciation 3.83M 4.68M 2.38M 1.61M 0.93M
Other cashflows from investing activities 69.91M - - -13.76M -
Change to inventory -3.73M -1.66M -3.90M -5.47M -4.48M
Change to account receivables 0.22M -2.93M 0.68M 5.93M -11.28M
Sale purchase of stock - - -0.78M 1.44M 0.01M
Other cashflows from financing activities -1.56M -1.52M -1.87M 59.63M 29.97M
Change to netincome - - - 7.50M 4.60M
Capital expenditures 0.95M 0.60M 2.04M 2.04M 0.74M
Change receivables - - - 5.93M -11.28M
Cash flows other operating - - - 2.69M 0.76M
Cash and cash equivalents changes - - - -35.56M 64.91M
Change in working capital -15.30M -2.54M -1.57M 3.36M -12.44M
Stock based compensation 9.85M 11.76M 9.79M 7.21M 2.50M
Other non cash items -41.55M 28.34M 1.05M 0.58M 0.18M
Free cash flow -24.64M -30.85M -27.10M -22.98M -29.82M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MASS
908 Devices Inc
0.41
4.04%
10.56 - - 6.77 3.17 5.01 -3.15
ABT
Abbott Laboratories
-0.03
0.03%
109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-3.04
2.90%
101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-9.21
2.75%
325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-2.15
4.12%
49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

908 Devices Inc

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

44 3rd Avenue, Burlington, MA, United States, 01803

857 254 1500

172

Name Title Year Born
Dr. Kevin J. Knopp Ph.D. Co-Founder, CEO, Pres & Director 1973
Dr. Christopher David Brown Ph.D. Co-Founder, CTO, VP of R&D and Member of Scientific Advisory Board 1975
Mr. Steve Araiza Co-Founder NA
Mr. Andrew Bartfay Co-Founder & Director of Hardware Devel. NA
Mr. Michael Jobin Co-Founder & Director of Product Devel. NA
Dr. Scott Miller Ph.D. Co-founder & Director of MS Engineering NA
Mr. Joseph H. Griffith IV CFO & Treasurer 1975
Mr. Michael S. Turner Esq., J.D. VP, Sec. & Gen. Counsel 1967
Ms. Maura Fitzpatrick VP of Product Management & Marketing 1970
Dr. Trent A. Basarsky Ph.D. VP of Corp. Devel. 1968

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…